Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSan Francisco Veterans Affairs Medical Center

About this trial

Depression is a leading cause of morbidity and mortality, conferring substantial healthcare and societal costs. By studying methods to non-invasively target neural circuitry involved in reward responsivity, information generated by this project will improve understanding of the circuit alterations that underlie motivation and pleasure deficits in depression, and could also lead to the development of biologically-based markers of neurostimulation-based treatment response.

Eligibility criteria

Qualifiers

All participants

18-65 years old

Normal (or corrected to normal) vision

Participants with MDD

Disqualifiers

Premorbid IQ estimate < 70

Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive sequelae)

Loss of consciousness > 30 minutes or any loss of consciousness with neurological sequelae

Major medical conditions (e.g., seizure disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology), or other physical conditions if they preclude participation in EEG, TMS, or MRI protocols (e.g. peripheral nerve damage, limb paralysis etc.)

Trial design

Treatments tested in this trial

  • TMS: single session intermittent theta burst stimulation (iTBS) to dorsomedial prefrontal target in individuals with major depressive disorder, via MagVenture MagPro R30 device / Cool-DB80 A/P coil
  • SHAM (inactive) TMS stimulation

Treatment groups

45 Participants
are divided into 3 treatment groups